This Congress Hub is accessible to HCPs from around the world and has been reviewed in accordance with our US headquarter policies.
Learn about the mechanism of action and the potential promise of the BiTE® immuno-oncology platform.
Learn about KRAS and KRAS G12C mutations in cancer.